Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
HCB101
/
HanchorBio
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
||
||||||||
HCB101
/
HanchorBio
Enrollment status, Metastases:
A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRP?-CD47 Pathway, in Solid or Hematological Tumors
(clinicaltrials.gov) - Oct 3, 2023
P1
, N=60, Recruiting,
Sponsor: FBD Biologics Limited
Enrolling by invitation --> Recruiting
|||
|||||||
HCB101
/
HanchorBio
Enrollment open, Metastases:
A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRP?-CD47 Pathway, in Solid or Hematological Tumors
(clinicaltrials.gov) - Aug 21, 2023
P1
, N=60, Enrolling by invitation,
Sponsor: FBD Biologics Limited
Enrolling by invitation --> Recruiting Not yet recruiting --> Enrolling by invitation
|
|||||||||
HCB101
/
HanchorBio
New P1 trial, Metastases:
A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRP?-CD47 Pathway, in Solid or Hematological Tumors
(clinicaltrials.gov) - Jun 7, 2023
P1
, N=60, Not yet recruiting,
Sponsor: FBD Biologics Limited